EGFR T790M + KRAS mutation
|
NSCLC
|
EGFR T790M + KRAS mutation
|
NSCLC
|
gefitinib Resistant: C3 – Early Trials
|
gefitinib Resistant: C3 – Early Trials
|
EGFR T790M + KRAS mutation
|
NSCLC
|
EGFR T790M + KRAS mutation
|
NSCLC
|
erlotinib Resistant: C3 – Early Trials
|
erlotinib Resistant: C3 – Early Trials
|